About Bioline
Bioline is a Healthcare company based in London (United Kingdom) founded in 1992, and was acquired by Meridian Bioscience in July 2010. Bioline is engaged in providing reagents for molecular biology research. It operates on a Direct-to-Consumer (D2C) and Professional Services model. The company has 42 employees. Its website bioline.com draws about 43 thousand monthly visits. Bioline offers products and services including SensiFASTâ„¢ Kits, JetSeqâ„¢ Kits, and MyTaqâ„¢ Polymerases. Its focus areas include Biotechnology, Molecular Diagnostics and Research Tools. Its legal entity is Meridian Bioscience. Its competitors include Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec and 5 more; 8 of its 10 listed competitors have raised funding.
Company details
Bioline, a part of Meridian Bioscience, is focused on the development and supply of reagents for molecular biology applications. Products are designed for PCR, qPCR, and next-generation sequencing, supporting research in areas such as agricultural biotechnology, cancer research, drug discovery, epigenetics, molecular diagnostics, and stem cell research. Solutions are offered to facilitate gene expression analysis, genotyping, biomarker analysis, and nucleic acid purification across various scientific sectors.
- Headquarters London, United Kingdom
- Employees 42
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website bioline.com
- Social LinkedIn X
- Acquired by Meridian Bioscience (Jul 2010)
- Legal Name Meridian Bioscience
- Annual Revenue$68.23 M (USD)314as on Sep 03, 2020
- Net Profit$39.17 M (USD)686as on Sep 03, 2020
- Investors
- Employee Count42
- Acquired byMeridian Bioscience
(Jul 2010)
Products & Services of Bioline
Bioline offers a comprehensive portfolio of products and services, including SensiFAST™ Kits, JetSeq™ Kits, and MyTaq™ Polymerases.
Reagents for fast and sensitive qPCR applications are provided.
Library preparation kits for NGS sequencing are offered.
DNA polymerases for robust PCR amplification are supplied.
Investors in Bioline
Bioline has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Meridian Bioscience.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Molecular diagnostic device and kits | 1976 | meridianbioscience.com | Ohio, United States |
Investor details for Bioline
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Bioline
1 people are tracked at Bioline (1 in leadership); the tracked headcount is 42.
| Name | Role | Group |
|---|---|---|
Ludwik Pokorny | CEO | Leadership |
Complete people profiles for Bioline
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Bioline
2 dated milestones of Bioline across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Bioline is founded.
- Exit Acquired by Meridian Bioscience.
Competitors of Bioline
Bioline has 10 listed competitors in our database, 8 of them funded. They include Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| miltenyibiotec.com | 1989 | Bergisch Gladbach, Germany | – | 585 | Develops tools and products for research and clinical application | |
| devyser.com | 2004 | Stockholm, Sweden | $15.48M | – | Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders | |
| exonhit.com | 1997 | Paris, France | $65.46M | – | Fully integrated in vitro diagnostics company specializing in transplantation, infectious diseases and cancer diagnosis | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits |
Detailed competitors of Bioline
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bioline
The website of Bioline (bioline.com) receives about 42.9K visits a month.
- Monthly visits42.9K
▼ 18.1% vs previous month
Websites whose visitors overlap most with Bioline. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bio-rad.com | 100% | 665.2K | #79,666 | View details | |
| neb.com | 99% | 749.5K | #69,042 | View details | |
| qiagen.com | 91% | 458.2K | #105,023 | View details | |
| tocris.com | 75% | 226K | #220,543 | View details | |
| zymoresearch.com | 72% | 138.3K | #306,279 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Bioline
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Bioline (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bioline
Complete news archive for Bioline
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioline
Bioline was founded in 1992.
Bioline is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Bioline has 42 employees.
Annual revenue of Bioline is $68.23M as on Sep 03, 2020.
Bioline, a part of Meridian Bioscience, is focused on the development and supply of reagents for molecular biology applications. Products are designed for PCR, qPCR, and next-generation sequencing, supporting research in areas such as agricultural biotechnology, cancer research, drug discovery, epigenetics, molecular diagnostics, and stem cell research. Solutions are offered to facilitate gene expression analysis, genotyping, biomarker analysis, and nucleic acid purification across various scientific sectors.
Bioline's top competitors include Abcam, Sino Biological and Meridian Bioscience.
Bioline offers SensiFASTâ„¢ Kits, JetSeqâ„¢ Kits, and MyTaqâ„¢ Polymerases.
Bioline has 1 investor. Key investors include Meridian Bioscience.
Bioline operates through Meridian Bioscience.
Yes. Bioline was acquired by Meridian Bioscience in July 2010.